Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H21F3N8O |
| Molecular Weight | 446.4289 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=NC(=CN=C1N[C@H]2CCC[C@@H]2NC(=O)C3=NC=CC=C3N4N=CC=N4)C(F)(F)F
InChI
InChIKey=UFGCLPDMIZHEED-KBPBESRZSA-N
InChI=1S/C20H21F3N8O/c1-2-12-18(25-11-16(28-12)20(21,22)23)29-13-5-3-6-14(13)30-19(32)17-15(7-4-8-24-17)31-26-9-10-27-31/h4,7-11,13-14H,2-3,5-6H2,1H3,(H,25,29)(H,30,32)/t13-,14-/m0/s1
| Molecular Formula | C20H21F3N8O |
| Molecular Weight | 446.4289 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 19:23:10 GMT 2025
by
admin
on
Wed Apr 02 19:23:10 GMT 2025
|
| Record UNII |
PF6B68X8JN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
118308154
Created by
admin on Wed Apr 02 19:23:10 GMT 2025 , Edited by admin on Wed Apr 02 19:23:10 GMT 2025
|
PRIMARY | |||
|
PF6B68X8JN
Created by
admin on Wed Apr 02 19:23:10 GMT 2025 , Edited by admin on Wed Apr 02 19:23:10 GMT 2025
|
PRIMARY | |||
|
1803557-42-7
Created by
admin on Wed Apr 02 19:23:10 GMT 2025 , Edited by admin on Wed Apr 02 19:23:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
ASSAY (Functional)
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
For schizophrenia and related psychiatric conditions.
|
